-
Electronic (PDF)
-
Site License
-
Enterprisewide
Sunwin International Neutraceuticals, Inc. (SUWN) - Financial and Strategic SWOT Analysis Review
GlobalData, September 2011, Pages: 29
Sunwin International Neutraceuticals, Inc. (SUWN) - Financial and Strategic SWOT Analysis Review
Summary
Sunwin International Neutraceuticals, Inc. (Sunwin) is publicaly held company engaged in the manufacture, development and sale of a range of Neutraceuticals products inclusive of sweeteners, Chinese medicines, veterinary medicines and animal feeds. All these products are prepared from herbal ingredients.. During fiscal year 2011 the company’s business operation were organized into two segments Stevioside, and Chinese Medicines. The Stevioside segment produces and sells various grades of stevioside, a natural low calorie sweetener; and Only Sweet, a stevioside-based table top sweetener that is used as a dietary supplement. The Chinese Medicines segment manufactures and sells traditional Chinese medicine formula extracts for use in products made for use by humans and animals. Sunwin products are recognized for quality and value. Company’s operations are carried out in China nad North America. The company is headquartered at Qufu in Shandong, China.
Sunwin International Neutraceuticals, Inc. Key Recent Developments
Mar 25, 2010: FDA Awards GRAS Status To Sunwin, Wild Multiple For Sunwin Stevia Extracts
This comprehensive SWOT profile of Sunwin International Neutraceuticals, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
List of Tables
List of Figures
Section 1 - About the Company
Sunwin International Neutraceuticals, Inc. - Key Facts
Sunwin International Neutraceuticals, Inc. - Key Employees
Sunwin International Neutraceuticals, Inc. - Key Employee Biographies
Sunwin International Neutraceuticals, Inc. - Major Products and Services
Sunwin International Neutraceuticals, Inc. - History
Sunwin International Neutraceuticals, Inc. - Company Statement
Sunwin International Neutraceuticals, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Sunwin International Neutraceuticals, Inc. - Business Description
Sunwin International Neutraceuticals, Inc. - SWOT Analysis
SWOT Analysis - Overview
Sunwin International Neutraceuticals, Inc. - Strengths
Strength - Broad Product Portfolio
Strength - Strong Liquidity Position
Strength - Increasing Global Acceptance
Weakness - Declining Market Share
Weakness - Declining Market Share in Sector
Weakness - Declining Operating Margin
Weakness - Low Return on Equity
Opportunity - Emerging Markets
Opportunity - Availability of Veterinary Medicine
Threat - Intense Competition
Threat - Tightening of FDA’s Regulatory Oversight
Threat - Uncertain R&D Outcomes
Sunwin International Neutraceuticals, Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Recent Developments
Mar 25, 2010: FDA Awards GRAS Status To Sunwin, Wild Multiple For Sunwin Stevia Extracts
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Sunwin International Neutraceuticals, Inc., Key Facts
Sunwin International Neutraceuticals, Inc., Key Employees
Sunwin International Neutraceuticals, Inc., Key Employee Biographies
Sunwin International Neutraceuticals, Inc., Major Products and Services
Sunwin International Neutraceuticals, Inc., History
Sunwin International Neutraceuticals, Inc., Subsidiaries
Sunwin International Neutraceuticals, Inc., Key Competitors
Sunwin International Neutraceuticals, Inc., Ratios based on current share price
Sunwin International Neutraceuticals, Inc., Annual Ratios
Sunwin International Neutraceuticals, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Sunwin International Neutraceuticals, Inc., Performance Chart (2007 - 2011)
Sunwin International Neutraceuticals, Inc., Ratio Charts
China Shenghuo Pharmaceutical Holdings, Inc.
Tianyin Pharmaceutical Co., Inc.
HARBIN PHARMACEUTICAL GROUP CO., LTD.
China Health Resource, Inc.
Sinphar Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co., Ltd.
China Sky One Medical, Inc.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
